SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 195 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 1,175,000 | $26,273,000 | 6.18% |
| Aisling Capital Management LP | 1,025,000 | $22,919,000 | 4.12% |
| FRAZIER MANAGEMENT LLC | 1,435,045 | $32,088,000 | 2.57% |
| Avidity Partners Management LP | 3,846,000 | $85,997,000 | 2.38% |
| COMMODORE CAPITAL LP | 236,500 | $5,288,000 | 2.11% |
| ACUTA CAPITAL PARTNERS, LLC | 255,180 | $5,706,000 | 2.06% |
| Boxer Capital, LLC | 2,287,782 | $51,155,000 | 1.74% |
| Altium Capital Management LP | 253,448 | $5,667,000 | 1.57% |
| Affinity Asset Advisors, LLC | 190,500 | $4,260,000 | 1.45% |
| VR Adviser, LLC | 591,782 | $13,232,000 | 1.44% |